瘀血痹片通过调控LXA4-FPR2-TRPA1通路缓解小鼠炎性疼痛
该研究在完全弗氏佐剂诱导的小鼠炎性疼痛模型中,观察瘀血痹片(YXB)的镇痛机制。结果显示YXB可提高机械痛阈、减轻热痛敏及焦虑抑郁行为,减少爪部巨噬细胞浸润和TRPA1表达,升高LXA4水平并抑制LTA4H表达;FPR2拮抗剂可阻断其促炎症消退和镇痛效应,提示LXA4-FPR2-TRPA1通路是关键机制。
要点
- YXB可缓解CFA小鼠机械痛敏、热痛敏及焦虑抑郁行为。
- YXB减少爪部CD68+和F4/80+CD11b+巨噬细胞浸润。
- YXB镇痛促消退作用依赖LXA4-FPR2-TRPA1通路。
核心结论
- YXB可调控CFA小鼠爪部氧化脂质促进炎症消退,LXA4-FPR2-TRPA1通路是其镇痛关键机制。
研究设计与样本
- 研究为动物实验,采用完全弗氏佐剂(CFA)诱导的小鼠炎性疼痛模型。
主要发现
- YXB升高CFA小鼠机械痛敏阈值,减轻热痛敏及焦虑抑郁行为。
- YXB减少爪部CD68+细胞数和F4/80+CD11b+细胞比例,降低巨噬细胞浸润。
- YXB降低爪部TRPA1及DRG中TRPV1表达,抑制外周敏化。
- YXB调节DHA来源氧化脂质,升高爪部LXA4水平并抑制LTA4H表达。
- FPR2拮抗剂WRW4可阻碍YXB的促消退和镇痛效应;与AITC组相比YXB抗炎镇痛效果无显著改善。
临床怎么用
- 该研究为动物实验,临床用于炎性疼痛仍需人体证据支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oxylipins including lipoxin A4 (LXA4) facilitate the resolution of inflammation and possess analgesic properties by inhibiting macrophage infiltration and transient receptor potential (TRP) protein expression. Yu-Xue-Bi Tablet (YXB) is a traditional Chinese patent medicine used to relieve inflammatory pain. Our previous research has shown that the analgesic effect of YXB is related to inhibiting peripheral inflammation and regulating macrophage infiltration, but the mechanism is not yet clear. The purpose of this study is to explore the mechanisms of YXB on mice models with Complete Freund's Adjuvant (CFA)-induced inflammatory pain from the perspective at the resolution of inflammation. METHODS: Mechanical allodynia thresholds and heat hypersensitivity were measured using the Von Frey test and the hot plate test respectively. The open field test and the tail suspension test were employed to measure anxiety and depressive behaviors respectively. The expression of CD68+ and the proportion of F4/80+CD11b+ cells were measured by immunofluorescence staining and flow cytometry. The expression of transient receptor potential ankyrin 1(TRPA1) was measured by immunofluorescence staining and western blotting. Oxylipins omics analysis provided quantitative data on oxylipins in the paws, and enzyme linked immunosorbent assay (ELISA) was used to measure the levels of LXA4 there. Immunofluorescence staining was used to perform the expression of Leukotriene A4 hydroxylase (LTA4H) in the paws of mice. The impact of injecting the formyl peptide receptor 2(FPR2) antagonist WRW4 and the TRPA1 agonist AITC into the left paws was observed, focusing on the expression of mechanical allodynia thresholds, the expression of CD68+, TRPA1 in the paws, and Calcitonin gene-related peptide (CGRP) in the L5 spinal dorsal horn. RESULTS: YXB elevated mechanical allodynia thresholds, alleviated heat hypersensitivity and anxiety and depressive behaviors in CFA mice. It significantly reduced the number of CD68+ and proportion of F4/80+CD11b+ within the paws, thereby decreasing macrophage infiltration. Additionally, it diminished the expression of TRPA1 in the paws and TRPV1 in the DRG, leading to an inhibition of peripheral sensitization. Through quantitative analysis, it was found that YXB could modulate DHA-derived oxylipins and LXA4. ELISA results indicated that YXB elevated the levels of LXA4 and inhibited the expression of LAT4H in the paws. Furthermore, the pro-resolution and analgesic effects of YXB were hindered after administration of the FPR2 antagonist. Compared with the AITC group, YXB showed no significant improvement in anti-inflammatory and analgesic effects. CONCLUSIONS: YXB can regulate the oxylipins of paws in CFA mice to promote the resolution of inflammation. The LXA4-FPR2-TRPA1 pathway is a key mechanism for the resolution of inflammation and analgesic effects.
引用
- Liu Y, Zhang G, Zhu C, et al. The analgesic effects of Yu-Xue-Bi tablet (YXB) on mice with inflammatory pain by regulating LXA4-FPR2-TRPA1 pathway. Chin Med. 2024. PMID: 39107849. doi:10.1186/s13020-024-00975-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。